Cannabis Law Report

DECEMBER 27, 2019

Moreover over half of current cannabis users (52%) used apps on their mobile phone/tablet yesterday, with 66% reporting mobile app usage in the past week, and 74% reporting use in the past month, according to Vividata’s Spring Cannabis Consumer Study 2019. AI-Powered search platform maximizes access to publications.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

NOVEMBER 10, 2019

Exclusive data collaboration between The Green Fund and Freshleaf Analytics. In April 2019, QLD amended their patient access process making it easier for doctors to write prescriptions. QLD is also well serviced with a variety of access clinics, which would have contributed to this relative increase. A 361% increase.

Access 45

Access Medicine Data Patients 45

Cannabis Law Report

JANUARY 29, 2020

In 2019, California cannabis consumers continued to learn about and turn to cannabis to address their various needs. To provide a picture of California’s legal cannabis marketplace, we’ve aggregated our proprietary data to illustrate the behavior of over half a million cannabis consumers who purchased via the Eaze platform in 2019.

Vaping 59

Vaping Edibles Topical Concentrates 59

NORML

AUGUST 29, 2019

” Specifically, federal and state data finds that teen cannabis use has declined in past years – during the same time that many states have legalized and regulated the use of cannabis by adults. According to an August 2019 federal report , past-year marijuana use by those ages 12 to 17 has fallen consistently since 2002, from 15.8

Education 226

Education Data Retail Environment 226

NORML

APRIL 7, 2020

Incidences of the vaping-related lung illness EVALI (e-cigarette or vaping product use-associated lung injury) are primarily concentrated to jurisdictions where adult-use cannabis consumption is prohibited, according to data published in the Journal of the American Medical Association (JAMA) Network Open.

Vaping 289

Vaping Legalization Concentrates Access 289

Cannabis Law Report

JULY 26, 2019

Snohomish, WA — 7/24/2019 — Facebook, Cambridge Analytica, Google+… the list of data sharing scandals is long and filled with multi-million-dollar corporations. 420A3 decided to forego the “traditional revenue stream” that includes sharing/selling their data. How do these other companies get all this data? .

Data 40

Data Policy Collective Consumption 40

Cannabis Law Report

OCTOBER 10, 2019

They have data and reports in play and we presume have fairly healthy numbers in terms of B to B clients. October 10, 2019. said New Frontier Data Founder and CEO Giadha Aguirre de Carcer. based New Frontier Data was founded in 2014 and has grown to over a 50-person team, with three offices in the United States and Europe.

Data 40

Data Media Banking Cannabis 40

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 105

Consumption Patients Research and Development Data 105

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. 1, 2019, the day legal sales began, and Sept. The deadline for proposals is Friday, July 16. Between Dec.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

Canna Law Blog

SEPTEMBER 18, 2023

with bipartisan support since 2019. The public likes it too: here’s a November 2022 Data for Progress poll revealing that “By a +65-point margin, voters support ensuring that banks do not discriminate against legitimate marijuana-related businesses.” It just won’t pass and it just won’t die.

Banking 82

Banking Access Business Compliance 82

Cannabis Law Report

OCTOBER 4, 2021

Also missing: hard data about it. First published in 2017, and updated in 2019, the new 2021 Women & Minorities in the Cannabis Industry , is now available for download here. First published in 2017, and updated in 2019, the new 2021 Women & Minorities in the Cannabis Industry , is now available for download here.

Data 52

Data Programs Business Banking 52

NORML

JANUARY 24, 2019

Sixty-six percent of US adults believe that “the use of marijuana should be made legal,” according to national survey data compiled by the Gallup. ” Never in modern history has there existed greater public support for ending the nation’s nearly century-long experiment with marijuana prohibition.

History 190

History Legislation Data Policy 190

Cannabis Law Report

MAY 4, 2020

MJ Biz writes…Only …… Approximately 333 patients accessed Denmark’s medical cannabis pilot scheme in the final quarter of 2019, according to recently released data from the … Read More.

Programs 59

Programs Data Access Patients 59

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

MAY 12, 2022

Back in 2019, the UK loosened their rules around medical cannabis and allowed a handful of cannabis-derived drugs to be prescribed. Still, only a small number of patients actually get medical cannabis prescriptions and accessibility is still a hot button issue in the country.

Terpenes 52

Terpenes Extraction Advocacy Patients 52

Veriheal

JANUARY 7, 2022

After the 2019 vape crisis that resulted in at least 68 deaths across the U.S., Based on the study’s data, the use of cannabis among 12th graders over the last several years has consistently remained around the 35% mark. and Canada. this growing preference is concerning to many. The Vape Crisis and Illicit Market Products.

Vaping 97

Vaping Education Data Consumption 97

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 billion, servicing nearly 340,000 active patients. . About RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

SEPTEMBER 9, 2021

From the systemic history of racism in the United States, African Americans exclusion from economic opportunities leads to maximizing profits for the White elite (Hirschman, 2019). Data were analyzed based on the central question, and three themes emerged. Theme 3 involved access to capital. Central Research Question.

Policy 105

Policy Research and Development Collective Banking 105

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. Accessed August 2021. 2019 Mar; 4(1): 73–84.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Veriheal

MARCH 29, 2023

In addition, several other studies suggest that legalizing access to marijuana is actually associated with decreased: Crime Opioid overdose Mental illness rates Gone are the days when cautionary tales run rampant. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2 1, 2003, to Dec.

Legalization 57

Legalization Data Policy Cannabis 57

Cannabis Law Report

OCTOBER 13, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. and his conclusion. Read the full article at [link].

Research and Development 52

Research and Development Therapy Access Data 52

Veriheal

AUGUST 28, 2020

The survey found that from 2009-2019 there were “no change” in the rate of cannabis consumption among high school students. Using the same data analyzed under a quadratic change model, lifetime cannabis consumption showed a clear decrease during that same time period. According to the recent CDC report, 21.7%

Consumption 52

Consumption Legalization Data Policy 52

SpeedWeed

AUGUST 31, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. 6, 2019, and Dec. 6, 2019, and Dec. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate.

Programs 72

Programs Patients Dispensary Cultivation 72

SpeedWeed

AUGUST 22, 2021

The MS Society is taking a stand on the lack of progress and access to cannabis in the UK, especially since medical cannabis has been legal there for almost three years. deserves access to effective?treatments.” treatments.” . The organization’s report states that Sativex is only supported by 49 out of 106 CCGs. ApprovedButDenied.

Sleep 52

Sleep Access Patients Treatment 52

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. Results highlight the need for expanded patient access to CBD products.”. CBD for hypertension.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

JUNE 20, 2022

Some specific highlights from the report are: A significant majority (64%) of cannabis accessed for consumption among past-month cannabis users in Maine is estimated to come from a regulated or otherwise legal source. About the OCP: The Mills Administration created OCP within DAFS in February 2019.

Programs 52

Programs Policy Consumption Access 52

SpeedWeed

MARCH 12, 2021

By 2019, concentrates took up a third of the market and flower was below 50%. As recently as 2014, the vast majority of medical and recreational cannabis sold in Colorado was flower and only 11% was the high-potency concentrates consumed through dab rigs or vape pens. Read more at The Denver Post ].

Recreational 52

Recreational Business Law Legalization 52

Cannabis Law Report

NOVEMBER 3, 2021

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK. Both virtual and in-person appointments can be made via the website www.zereniaclinic.co.uk.

Therapy 52

Therapy Access Patients Treatment 52

Cannabis Law Report

JANUARY 1, 2020

Now, it appears, that cannabis content could be on the same trajectory as new data is shows a 42.7 percent increase in total streamed hours for cannabis-related shows in 2019. Data shows 42.7 percent increase in total streamed hours for cannabis-related shows in 2019.

Data 66

Data Banking Cannabis Programs 66

Veriheal

NOVEMBER 18, 2022

Texas’ consistent gains can, in large part, be attributed to its recent efforts to increase access to its program. Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined. Hemp Study Shows Challenges of Regulation.

Edibles 86

Edibles Hemp Epilepsy Programs 86

SpeedWeed

MAY 25, 2021

Researchers collected data from the 2019-2020 National Health and Resilience in Veterans Study, a national survey that asks veterans to self-report their physical and mental health as well as their recent substance use. An analysis of the survey data revealed that 11.9 View original article.

Chronic Pain 52

Chronic Pain Marijuana Data Programs 52

Cannabis Law Report

MARCH 17, 2022

The national consumption of methylamphetamine, cocaine, MDMA and heroin increased year on year in the first four years of the Program (2016-17 to 2019-20), followed by a marked reduction in total consumption in year five (2020-21). The latest report presents data on Australia’s drug consumption for 12 substances. million Australians.

Consumption 52

Consumption Programs Data Treatment 52

Cannabis Law Report

DECEMBER 9, 2019

However, as reported by New Frontier Data reports, there are two selling points that are overwhelmingly driving growth: reducing anxiety and reducing inflammation. American Pet Products Association reports that U.S. pet owners spent over $70 billion in 2018 on non-CBD products for their pets.

Pets 59

Pets CBD Research and Development Epilepsy 59

SpeedWeed

AUGUST 31, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. 6, 2019, and Dec. 6, 2019, and Dec. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate.

Consumption 57

Consumption Programs Patients Dispensary 57